Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03593772
Other study ID # D2775-R
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 3, 2019
Est. completion date October 31, 2022

Study information

Verified date January 2023
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project is responsive to RR&D's current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. This project aligns with the VA mandate for complementary and integrative health (CIH) care for Veterans and their families. CIH complements traditional care for Veterans managing chronic conditions, such as chronic pain and PTSD. Mission Reconnect (MR) is a user-driven, dyadic, CIH self-care management program delivered remotely that teaches techniques the Veteran/partner dyad can use to reduce pain, anxiety and stress, promote well-being and improve relationship quality. The research goal is to evaluate MR as an approach to manage chronic pain and PTSD symptoms, for potential subsequent implementation. This study will possibly provide a model for establishing remote access and sustainable implementation of CIH within VA.


Description:

Chronic pain is one of the most prevalent medical conditions in the Veteran population. Pain often presents with comorbid conditions, specifically post-traumatic stress disorder (PTSD). Comorbid chronic pain and PTSD significantly impact the quality of life of Veterans and their families. Multi-faceted therapies leveraging complementary and integrative health (CIH) are mandated within VA to complement clinical practice guidelines improve Veterans' quality of life and ability to function. This research will evaluate a CIH intervention to manage pain and PTSD related outcomes within a bio-psychosocial framework. The proposed intervention, Mission Reconnect (MR), a user-driven, dyadic, self-care management program delivered online and by mobile app that has previously shown to be effective in a non-clinically defined community-based Veteran/military population. This research is needed to test MR's effects in a clinically defined population as a complement to clinical services to assess for potential subsequent implementation within the Department of Veterans Affairs (VA). This proposal resubmission is responsive to Veterans' reported desire for CIH and several VA initiatives, including RR&D's current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. The VA Secretary of Health Strategic Priorities and the emerging VA Whole Health Program identify access to CIH for pain and self-care management as a priority to achieve optimal Veteran health. To be responsive to these priorities the 2016 VA State-of-the-Art Conference (SOTA) and Comprehensive Addiction Recovery Act (CARA) mandated VA's commitment to conduct rigorous research to integrate non-pharmacological and CIH approaches into care, with emphasis on pain management. This proposal is also responsive to the VA's Opioid Safety Initiative (OSI) and Pain Care Mission which prioritize the need for nonpharmacological treatment options for pain. The short-term goal of this study is to determine the effects of MR on (1) chronic pain, PTSD and related outcomes and (2) relationship outcomes for Veterans and their partners. The long-term goal is to determine the effectiveness and sustainability of using CIH self-care management programs like MR to improve outcomes for Veterans with chronic pain and PTSD, and their partners. The investigators propose a four-year mixed-methods randomized controlled trial of MR with two arms (treatment & wait-list control) in a clinical sample of Veterans with comorbid pain and PTSD, and their partners (e.g., spouse). The specific aims are to: (Aim 1) Determine MR effectiveness for physical (pain, sleep), PTSD (intrusion, arousal, avoidance, numbing), and psychological (depression, stress, anxiety) symptoms, and global health (quality of life); (Aim 2) Determine MR effectiveness for social (relationship satisfaction, compassion for self/others) outcomes among Veterans and their partners; and (Aim 3) Describe Veteran and partner perceived value of MR in a sub-sample of participants. The sample will consist of Veteran and partner dyads (N = 336) at the Ann Arbor, Puget Sound, and Tampa VA facilities. Aim 1 & 2 data collection will include self-report assessment of 4-data points over a 4-month period to evaluate physical, psychological, and social outcomes. Eight weekly reports will also be collected for the first two months of MR use to assess MR utilization, and pain and stress levels. Aim 3 data collection will include telephone interviews from a randomly selected sub-sample of MR treatment group dyads (n = 42) to examine MR user experiences and their suggestions making MR useful for Veterans and their partners.


Recruitment information / eligibility

Status Completed
Enrollment 472
Est. completion date October 31, 2022
Est. primary completion date October 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 17 Years
Eligibility Inclusion Criteria: - English-speaking Veterans with chronic musculoskeletal pain. - Veteran is considered to have chronic musculoskeletal pain if he or she meeting either of two validated criteria: - (1) Having 2+ occurrences of any of targeted musculoskeletal ICD-9-CM codes "likely to represent chronic pain" recorded at visits separated by at least 30 days within past six months - (2) Having high impact chronic pain = 2+ occurrences of targeted musculoskeletal ICD-9-CM codes separated by at least 30 days within the past six months previous to study recruitment and two or more pain scores greater than or equal to 4 separated by at least 30 days within past six months. - For pain scores, the investigators will use the 0-10 numeric pain rating scale that is routinely collected at the VA. - The investigators will count two ICD-9-CM codes or pain scores recorded on the same day as one code/score. - Veteran is considered to have PTSD if he or she has a flag in his/her record indicating confirmed condition by the VA Compensation and Benefits program, has at least two outpatient visits in the year with the primary diagnosis being listed as PTSD (ICD-9-CM code 309.81) and/or had PTSD listed on the problem list], Veteran must also have PTSD (defined by PTSD diagnosis-ICD-9-CM 309.81), the ability to access and use an electronic platform (e.g. Mobile device, internet, DVD) for MR delivery, with a willing partner to also participate in the study and MR program. Exclusion Criteria: - Moderate to severe TBI - Diagnosis or documented treatment for psychosis in previous 6 months - Currently in substance use disorder treatment - Non-English speaking - Visual, hearing, cognitive impairment that prevent participation or ability to consent - And/or lack of access to internet service - These individuals will be excluded due to medical, language, and technology access issues that would prevent safe and full study participation. - Pain and PTSD treatment will not be factored as an inclusion/exclusion criteria but will be evaluated as covariates. - Potential participants who screen for aggression or violence will also be excluded from study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mission Reconnect
This four-year randomized controlled trial with one intervention arm and one wait-list control arm will utilize mixed methods to evaluate the effectiveness and perceived value of the MR program in relation to physical and psychological symptoms, global health, and social outcomes.

Locations

Country Name City State
United States VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan
United States VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington
United States James A. Haley Veterans' Hospital, Tampa, FL Tampa Florida

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Veteran perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting what are the experiences of participants using MR. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Other Veteran perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting type of recommendations participants have for promoting use of MR. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Other Veteran perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting number of domains/taxonomies related to participants' experiences with MR use. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Other Veterans' partners perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting what are the experiences of participants using MR. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Other Veterans' partners perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting type of recommendations participants have for promoting use of MR. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Other Veterans' partners perceived value of Mission Reconnect in a sub-sample of Veteran participants Measured by collecting number of domains/taxonomies related to participants' experiences with MR use. Scale for satisfaction of MR program will be used, measurements include 1 (strongly disagree ) to 10 (strongly agree). 18 months
Primary Mission Reconnect effectiveness for physical symptoms Measured by collecting number of participants that self-report pain outcomes after Mission Reconnect is used. Scale of 0 (no pain) -5 (worst pain) will identify intensity of pain. Activity tracking form will indicate number or participants. 24 months
Primary Mission Reconnect effectiveness for PTSD symptoms Measured by collecting number of participants that self-report PTSD symptoms after Mission Reconnect is used. Activity tracking form will indicate number or participants. 24 months
Primary Mission Reconnect effectiveness for psychological symptoms Measured by collecting number of participants that self-report psychological symptoms after Mission Reconnect is used. Activity tracking form will indicate number or participants. 24 months
Primary Mission Reconnect effectiveness for global health Measured by collecting number of participants that self-report global health stress outcomes after Mission Reconnect is used. Scale of 0 (no stress) to 5 (worst stress) will identify level of stress. Activity tracking form will indicate number or participants. 24 months
Secondary Mission Reconnect effectiveness for social outcomes among Veterans Measured by collecting number of participants that self-report social outcomes after Mission Reconnect is used. Activity tracking form will indicate number or participants. 24 months
Secondary Mission Reconnect effectiveness for social outcomes among Veterans' partners Measured by collecting number of participants that self-report social outcomes after Mission Reconnect is used. Activity tracking form will indicate number or participants. 24 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03962504 - Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial N/A
Completed NCT01995123 - Behavioral Activation for Smoking Cessation in PTSD N/A
Not yet recruiting NCT06278922 - Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma N/A
Completed NCT04597450 - Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03429166 - Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas N/A
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT03504722 - Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD N/A
Completed NCT04305353 - Intensive Care Unit (ICU) Diary Project N/A
Completed NCT03113890 - McLean and Genomind Prospective Study N/A
Withdrawn NCT05173831 - Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans Phase 2
Not yet recruiting NCT04056767 - Changes in Digital Phenotype During PE Therapy
Withdrawn NCT03924297 - Chilipad for Sleep and Symptoms of PTSD N/A
Withdrawn NCT03216356 - Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD Phase 2/Phase 3
Completed NCT03158558 - Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD N/A
Completed NCT03343028 - Biomarker Establishment for Superior Treatment of PTSD
Completed NCT02370173 - A Non-Pharmacological Method for Enhancing Sleep in PTSD N/A
Completed NCT01955538 - The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees. Phase 3
Completed NCT01911585 - Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure N/A
Withdrawn NCT01957371 - Mindful Yoga Therapy for Veterans With PTSD and Pain N/A